184 related articles for article (PubMed ID: 8693551)
21. A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7.
Wu Y; Guo Y; Liu Y
J Exp Med; 1993 Nov; 178(5):1789-93. PubMed ID: 8228824
[TBL] [Abstract][Full Text] [Related]
22. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.
Sayegh MH; Zheng XG; Magee C; Hancock WW; Turka LA
Transplantation; 1997 Dec; 64(12):1646-50. PubMed ID: 9422396
[TBL] [Abstract][Full Text] [Related]
23. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.
Kim KS; Denton MD; Chandraker A; Knoflach A; Milord R; Waaga AM; Turka LA; Russell ME; Peach R; Sayegh MH
Am J Pathol; 2001 Mar; 158(3):977-86. PubMed ID: 11238045
[TBL] [Abstract][Full Text] [Related]
24. Combined coinhibitory and costimulatory modulation with anti-BTLA and CTLA4Ig facilitates tolerance in murine islet allografts.
Truong W; Plester JC; Hancock WW; Merani S; Murphy TL; Murphy KM; Kaye J; Anderson CC; Shapiro AM
Am J Transplant; 2007 Dec; 7(12):2663-74. PubMed ID: 17983390
[TBL] [Abstract][Full Text] [Related]
25. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression.
Guillot C; Mathieu P; Coathalem H; Le Mauff B; Castro MG; Tesson L; Usal C; Laumonier T; Brouard S; Soulillou JP; Lowenstein PR; Cuturi MC; Anegon I
J Immunol; 2000 May; 164(10):5258-68. PubMed ID: 10799887
[TBL] [Abstract][Full Text] [Related]
26. CTLA4Ig attenuates accelerated rejection (presensitization) in the mouse islet allograft model.
Roy-Chaudhury P; Nickerson PW; Manfro RC; Zheng XX; Steiger J; Li YS; Strom TB
Transplantation; 1997 Jul; 64(1):172-5. PubMed ID: 9233722
[TBL] [Abstract][Full Text] [Related]
27. Comparative strategies to induce long-term graft acceptance in fully allogeneic renal versus cardiac allograft models by CD28-B7 T cell costimulatory blockade: role of thymus and spleen.
Schaub M; Stadlbauer TH; Chandraker A; Vella JP; Turka LA; Sayegh MH
J Am Soc Nephrol; 1998 May; 9(5):891-8. PubMed ID: 9596088
[TBL] [Abstract][Full Text] [Related]
28. Prolongation of islet allograft survival by coexpression of CTLA4Ig and CD40LIg in mice.
Li ZL; Xue WJ; Tian PX; Ding XM; Tian XH; Feng XS; Hou J
Transplant Proc; 2007 Dec; 39(10):3436-7. PubMed ID: 18089400
[TBL] [Abstract][Full Text] [Related]
29. CTLA4ig induces long-term graft survival of allogeneic skin grafts and totally inhibits T-cell proliferation in LFA-1-deficient mice.
Malm H; Corbascio M; Osterholm C; Cowan S; Larsen CP; Pearson TC; Ekberg H
Transplantation; 2002 Jan; 73(2):293-7. PubMed ID: 11821746
[TBL] [Abstract][Full Text] [Related]
30. CD28-independent costimulation of T cells in alloimmune responses.
Yamada A; Kishimoto K; Dong VM; Sho M; Salama AD; Anosova NG; Benichou G; Mandelbrot DA; Sharpe AH; Turka LA; Auchincloss H; Sayegh MH
J Immunol; 2001 Jul; 167(1):140-6. PubMed ID: 11418642
[TBL] [Abstract][Full Text] [Related]
31. Cardiac allograft tolerance induced by intra-arterial infusion of recombinant adenoviral CTLA4Ig.
Yang Z; Rostami S; Koeberlein B; Barker CF; Naji A
Transplantation; 1999 Jun; 67(12):1517-23. PubMed ID: 10401757
[TBL] [Abstract][Full Text] [Related]
32. Immunomodulation of pancreatic islet allografts in mice with CTLA4Ig secreting muscle cells.
Chahine AA; Yu M; McKernan MM; Stoeckert C; Lau HT
Transplantation; 1995 May; 59(9):1313-8. PubMed ID: 7762068
[TBL] [Abstract][Full Text] [Related]
33. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
Azuma H; Chandraker A; Nadeau K; Hancock WW; Carpenter CB; Tilney NL; Sayegh MH
Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12439-44. PubMed ID: 8901600
[TBL] [Abstract][Full Text] [Related]
34. Beneficial effects of costimulatory blockade with anti-inducible costimulator antibody in conjunction with CTLA4Ig on prevention of islet xenograft rejection from rat to mouse.
Nabeyama K; Yasunami Y; Toyofuku A; Nakano M; Satoh M; Matsuoka N; Ono J; Kamada M; Uede T; Todo S; Ikeda S
Transplantation; 2004 Dec; 78(11):1590-6. PubMed ID: 15591946
[TBL] [Abstract][Full Text] [Related]
35. In situ protection against islet allograft rejection by CTLA4Ig transduction.
Londrigan SL; Sutherland RM; Brady JL; Carrington EM; Cowan PJ; d'Apice AJ; O'Connell PJ; Zhan Y; Lew AM
Transplantation; 2010 Nov; 90(9):951-7. PubMed ID: 20808263
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of cellular immune responses to encapsulated porcine islet xenografts by simultaneous blockade of two different costimulatory pathways.
Safley SA; Kapp LM; Tucker-Burden C; Hering B; Kapp JA; Weber CJ
Transplantation; 2005 Feb; 79(4):409-18. PubMed ID: 15729166
[TBL] [Abstract][Full Text] [Related]
37. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo.
Akalin E; Chandraker A; Russell ME; Turka LA; Hancock WW; Sayegh MH
Transplantation; 1996 Dec; 62(12):1942-5. PubMed ID: 8990393
[TBL] [Abstract][Full Text] [Related]
38. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
Peach RJ; Bajorath J; Brady W; Leytze G; Greene J; Naemura J; Linsley PS
J Exp Med; 1994 Dec; 180(6):2049-58. PubMed ID: 7964482
[TBL] [Abstract][Full Text] [Related]
39. T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen.
Chandraker A; Russell ME; Glysing-Jensen T; Willett TA; Sayegh MH
Transplantation; 1997 Apr; 63(8):1053-8. PubMed ID: 9133464
[TBL] [Abstract][Full Text] [Related]
40. Co-stimulatory molecules in islet xenotransplantation: CTLA4Ig treatment in CD40 ligand-deficient mice.
Benda B; Ljunggren HG; Peach R; Sandberg JO; Korsgren O
Cell Transplant; 2002; 11(7):715-20. PubMed ID: 12518898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
